Your session is about to expire
← Back to Search
IT platform and patient navigation for Cancer (mFOCUS Trial)
N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 240 days
Awards & highlights
mFOCUS Trial Summary
This study is evaluating whether a system of care can improve cancer screening rates.
mFOCUS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 240 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~240 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Completion of follow-up test
Secondary outcome measures
Amount of time to complete the required diagnostic evaluation
mFOCUS Trial Design
4Treatment groups
Active Control
Group I: IT platform and patient navigationActive Control1 Intervention
the IT platform available in Arm 3 and navigation to help with scheduling and to address social barriers to care.
Group II: IT platform with remindersActive Control1 Intervention
Access to an IT platform that will deliver both visit based and between visit reminders about abnormal cancer screening test results.
Group III: Standard of careActive Control1 Intervention
standard of care
Group IV: IT platformActive Control1 Intervention
Access to an IT platform for visit-based reminders about overdue abnormal cancer screening test results
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterOTHER
524 Previous Clinical Trials
2,531,361 Total Patients Enrolled
Brigham and Women's HospitalOTHER
1,609 Previous Clinical Trials
11,458,347 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,186,375 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger